Janelle Hart

In today’s world, it is easy to find information on the internet, whether it be through search engines or social media. Much of that information, however, is not reliable.

Although percutaneous tibial nerve stimulation (PTNS) is commonly used to treat overactive bladder, investigators continue to assess whether this neuromodulation technique is beneficial for patients with other urologic conditions.

Women are less likely to be diagnosed with bladder cancer, but that does not make the disease any less fatal for this population of patients.

Recurrent urinary tract infections (UTIs) place a large burden on women as they struggle to find the right remedies for this problem. According to guidelines, there is only 1 temporary cure for this condition and that is antibiotics. As more antibiotics are taken by this susceptible population, however, the bacteria can adapt and make recurrent UTI treatment in the future much more difficult.

Women who suffer from recurrent urinary tract infections (rUTIs) are typically treated with antibiotics. These treatment regimens, however, are associated with high rates of morbidity as the world faces rising antibiotic resistance.

As the COVID-19 pandemic prevails, many clinicians and patients question whether telemedicine will be the new mainstream form of health care.